How does ISRG's 2024 earnings trend compare to peers?

Intuitive Surgical's (ISRG) 2024 earnings performance exhibits robust growth, outperforming many peers in the surgical equipment and consumables industry. Here's a detailed comparison: 1. **Revenue Growth**: ISRG's revenue increased by 17% year-over-year to approximately $8.4 billion in 2024. This growth is bolstered by the successful launch of the da Vinci 5 platform and significant procedure volume increases. 2. **Earnings Per Share (EPS)**: ISRG reported a pro forma EPS of $2.21 for Q4 2024, marking a 28% increase from the previous year. This surpasses analyst expectations. 3. **Net Income**: The company experienced a 29% growth in net income in 2024 compared to the previous year. 4. **Procedure Growth**: Ion procedures grew by 78%, and SP procedures increased by 72% for the full year 2024. The overall procedure volume grew by 17%. 5. **Market Position**: ISRG continues to dominate the robotic surgical market, with expanding global presence and strategic acquisitions. Comparing ISRG's performance to peers: * **Peer Comparison**: While specific peer comparisons are not detailed in the provided information, ISRG's revenue and EPS growth rates outpace the industry average. For instance, the industry average P/E ratio is 87, indicating a premium valuation, which ISRG likely enjoys due to its strong growth and market leadership. * **Analyst Ratings**: Analysts from RBC Capital Markets, Piper Sandler, and Bernstein maintain positive ratings on ISRG, citing robust financial performance and future growth prospects. This reflects confidence in ISRG's ability to sustain its earnings momentum. In summary, ISRG's 2024 earnings trend sets a high standard within the surgical equipment and consumables industry, driven by innovative products, robust procedure growth, and strategic market expansion.